CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target
Authors
Keywords
-
Journal
Clinical & Translational Oncology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-15
DOI
10.1007/s12094-022-02792-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Endoglin and TGF-β signaling in glioblastoma
- (2021) Isabel Burghardt et al. CELL AND TISSUE RESEARCH
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Endoglin Expression and Microvessel Density as Prognostic Factors in Pediatric Rhabdomyosarcoma
- (2021) Joanna Radzikowska et al. Journal of Clinical Medicine
- Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
- (2021) Fahimeh Fattahi et al. Diagnostic Pathology
- The Role of Endoglin in Hepatocellular Carcinoma
- (2021) Kuo-Shyang Jeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current strategies of virotherapy in clinical trials for cancer treatment
- (2021) Weijian Lin et al. JOURNAL OF MEDICAL VIROLOGY
- A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors
- (2021) Eduardo Listik et al. PLoS One
- Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
- (2021) Claudia Ollauri-Ibáñez et al. Cancers
- Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer
- (2020) ADRIANA C. VIDAL et al. ANTICANCER RESEARCH
- Inhibition of endoglin exerts anti-tumor effects through the regulation of non-Smad TGF-β signaling in angiosarcoma
- (2020) Ryoko Sakamoto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Considering the role of radical prostatectomy in 21st century prostate cancer care
- (2020) Anthony J. Costello Nature Reviews Urology
- Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine
- (2020) Adriana C. Gamboa et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ImmunoPET: Concept, Design, and Applications
- (2020) Weijun Wei et al. CHEMICAL REVIEWS
- Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
- (2020) Ana Nogués et al. World Journal of Surgical Oncology
- CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma
- (2020) Amit Nair et al. CELLULAR ONCOLOGY
- Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo
- (2020) M. Fiedorowicz et al. Scientific Reports
- Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia
- (2020) Patricia E. de Almeida et al. Cancer Immunology Research
- In vivo gene delivery mediated by non-viral vectors for cancer therapy
- (2020) Reza Mohammadinejad et al. JOURNAL OF CONTROLLED RELEASE
- Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas
- (2020) Qi Zhang et al. Frontiers in Medicine
- Sustained activation of notch signaling maintains tumor-initiating cells in a murine model of liposarcoma
- (2020) Pei-Chieh Tien et al. CANCER LETTERS
- Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
- (2019) Junhui Hu et al. Stem Cells International
- Vessel co-option in cancer
- (2019) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- Diagnostic and prognostic biomarkers in cholangiocarcinoma
- (2019) Rocio I.R. Macias et al. LIVER INTERNATIONAL
- CircRNAs and lung cancer: Biomarkers and master regulators
- (2019) Xin Di et al. LIFE SCIENCES
- Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches
- (2019) Aaron J Franke et al. JNCI-Journal of the National Cancer Institute
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Strategies for Colorectal Cancer Screening
- (2019) Uri Ladabaum et al. GASTROENTEROLOGY
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Soluble CD105 is prognostic of disease recurrence in prostate cancer patients
- (2019) Veronica R Placencio-Hickok et al. ENDOCRINE-RELATED CANCER
- Pancreatic Cancer
- (2019) Alexandra Moore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling
- (2019) Kehua Zhang et al. EXPERIMENTAL CELL RESEARCH
- Imaging Tiny Hepatic Tumor Xenografts via Endoglin-Targeted Paramagnetic/Optical Nanoprobe
- (2018) Huihui Yan et al. ACS Applied Materials & Interfaces
- Endoglin based in vivo near-infrared fluorescence imaging of tumor models in mice using activatable liposomes
- (2018) Felista L. Tansi et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
- (2018) Virginia Di Paolo et al. BMC CANCER
- Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma
- (2018) Leili Saeednejad Zanjani et al. Cancer Biomarkers
- Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway
- (2018) Jian Chen et al. GASTROENTEROLOGY
- Contemporary Sarcoma Diagnosis, Genetics, and Genomics
- (2018) Inga-Marie Schaefer et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes
- (2018) Huiqin Zhuo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Kidney cancer in 2017: Challenging and refining treatment paradigms
- (2018) Mark W. Ball et al. Nature Reviews Urology
- Antagonizing CD105 enhances radiation sensitivity in prostate cancer
- (2018) Anisha Madhav et al. ONCOGENE
- Angiogenesis and radiological tumor growth in patients with glioblastoma
- (2018) Vilde Elisabeth Mikkelsen et al. BMC CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
- (2018) Chun-Yan Lan et al. LANCET ONCOLOGY
- Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
- (2018) Manabu Kato et al. ONCOGENE
- An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti‐Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma
- (2018) Toni K. Choueiri et al. ONCOLOGIST
- Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma
- (2018) Pilar Puerto-Camacho et al. CLINICAL CANCER RESEARCH
- Magnetic Endoglin Aptamer Nanoprobe for Targeted Diagnosis of Solid Tumor
- (2018) Liping Zhong et al. Journal of Biomedical Nanotechnology
- Clinical application of ultrasound-guided percutaneous microwave ablation in the treatment of T1aN0M0 stage renal carcinoma
- (2018) Guoqing Sui et al. Journal of Medical Ultrasonics
- Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature
- (2017) Zhong Zheng Jia et al. EUROPEAN JOURNAL OF RADIOLOGY
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin
- (2017) Kaja Lund et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Assessment of vascularity in glioblastoma and its implications on patient outcomes
- (2017) Ben G. McGahan et al. JOURNAL OF NEURO-ONCOLOGY
- Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis
- (2017) Young-Chan Kwon et al. JOURNAL OF VIROLOGY
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosis
- (2017) Muhammad Alsamman et al. LIVER INTERNATIONAL
- Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells
- (2017) Xiao-Fei Zhang et al. MOLECULAR CARCINOGENESIS
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- The role of microvessel density, lymph node metastasis, and tumor size as prognostic factors of distant metastasis in colorectal cancer
- (2017) Tomonari Cho et al. Oncology Letters
- Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells
- (2017) Junhui Hu et al. Stem Cell Reports
- Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer
- (2016) H. Luo et al. CLINICAL CANCER RESEARCH
- Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics
- (2016) Hongwei Jin et al. Journal of Proteomics
- Kidney cancer
- (2016) Brian Owens NATURE
- Comparative prognostic relevance of breast intra-tumoral microvessel density evaluated by CD105 and CD146: A pilot study of 42 cases
- (2016) Leandro Marcelo Martinez et al. PATHOLOGY RESEARCH AND PRACTICE
- Glioblastoma, hypoxia and autophagy: a survival-prone ‘ménage-à-trois’
- (2016) Soha Jawhari et al. Cell Death & Disease
- Engineering Intrinsically Zirconium-89 Radiolabeled Self-Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies
- (2016) Shreya Goel et al. Advanced Science
- Red Fluorescent Zinc Oxide Nanoparticle: A Novel Platform for Cancer Targeting
- (2015) Hao Hong et al. ACS Applied Materials & Interfaces
- A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
- (2015) Fatima H. Karzai et al. BJU INTERNATIONAL
- Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement
- (2015) Yasuyoshi Miyata et al. INTERNATIONAL JOURNAL OF UROLOGY
- Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma
- (2015) Dimitrios Lytras et al. PANCREAS
- Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma
- (2015) Liangjing Zhou et al. PATHOLOGY & ONCOLOGY RESEARCH
- Targeted Antiangiogenesis Gene Therapy Using Targeted Cationic Microbubbles Conjugated with CD105 Antibody Compared with Untargeted Cationic and Neutral Microbubbles
- (2015) Yu Zhou et al. Theranostics
- Annexin A2 and CD105 Expression in Pancreatic Ductal Adenocarcinoma is Associated with Tumor Recurrence and Prognosis
- (2015) Ya-Kai Huang et al. Asian Pacific Journal of Cancer Prevention
- CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
- (2015) Leandro Marcelo Martinez et al. PLoS One
- Theranostic Unimolecular Micelles Based on Brush-Shaped Amphiphilic Block Copolymers for Tumor-Targeted Drug Delivery and Positron Emission Tomography Imaging
- (2014) Jintang Guo et al. ACS Applied Materials & Interfaces
- Identification of Three Molecular and Functional Subtypes in Canine Hemangiosarcoma through Gene Expression Profiling and Progenitor Cell Characterization
- (2014) Brandi H. Gorden et al. AMERICAN JOURNAL OF PATHOLOGY
- Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression
- (2014) Juliana Passos Paschoal et al. BMC CANCER
- Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
- (2014) A Saroufim et al. BRITISH JOURNAL OF CANCER
- Thiol-PEG-carboxyl-stabilized Fe 2 O 3 /Au nanoparticles targeted to CD105: Synthesis, characterization and application in MR imaging of tumor angiogenesis
- (2014) Song Zhang et al. EUROPEAN JOURNAL OF RADIOLOGY
- Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105)
- (2014) Hirofumi Toi et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Lung Squamous Cell Carcinoma Tumor Microenvironment on the CD105+ Endothelial Cell Proteome
- (2014) Huiqin Zhuo et al. JOURNAL OF PROTEOME RESEARCH
- Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy
- (2014) Yasuyoshi Miyata et al. PROSTATE
- CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF
- (2014) Yan Li et al. TUMOR BIOLOGY
- Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy
- (2013) Zu-Sen Wang et al. BMC CANCER
- Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer
- (2013) R Rosa et al. BRITISH JOURNAL OF CANCER
- The expression and characterization of endoglin in uterine leiomyosarcoma
- (2013) Hiroko Mitsui et al. CLINICAL & EXPERIMENTAL METASTASIS
- Endoglin for tumor imaging and targeted cancer therapy
- (2013) Madelon Paauwe et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Ex Vivo Behaviour of Human Bone Tumor Endothelial Cells
- (2013) Teresa Infante et al. Cancers
- CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma
- (2012) Stuart J. Smith et al. ACTA NEUROPATHOLOGICA
- Endoglin (CD105) and Claudin-5 Expression in Cutaneous Angiosarcoma
- (2012) Hiroyuki Hara AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Transforming growth factor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocellular carcinoma
- (2012) Piera Balzarini et al. LABORATORY INVESTIGATION
- Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105
- (2011) Laurence M. Wood et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Endoglin (CD105) expression and angiogenesis status in small cell lung cancer
- (2010) Yukari Takase et al. PATHOLOGY RESEARCH AND PRACTICE
- Endoglin-Targeted Cancer Therapy
- (2010) Ben K. Seon et al. Current Drug Delivery
- Characterization of endoglin and Ki-67 expression in endothelial cells from benign and malignant lesions of the uterine cervix
- (2009) Anca M. Cimpean et al. PATHOLOGY INTERNATIONAL
- Endoglin in angiogenesis and vascular diseases
- (2008) Peter ten Dijke et al. ANGIOGENESIS
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- Transforming Growth Factor- 1 and CD105 Promote the Migration of Hepatocellular Carcinoma-Derived Endothelium
- (2008) A. Benetti et al. CANCER RESEARCH
- Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy
- (2008) R. S. Svatek et al. CLINICAL CANCER RESEARCH
- Endoglin (CD105) as a urinary and serum marker of prostate cancer
- (2008) Kazutoshi Fujita et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More